BMRN Biomarin Pharmaceutical PE ratio, current and historical analysis
As of Dec 20, 2024, the Biomarin Pharmaceutical stock's PE ratio is 38.62. This results from the current EPS of $1.7 and stock price of $65.66. The P/E ratio has a decrease of 47% from the past four quarters average of 72.7.
BMRN PE ratio history
The PE ratio of Biomarin Pharmaceutical has averaged 193.44 over the last five years. The current PE ratio of 38.62 is 80% below the historical average. Over the past five years, BMRN's PE ratio was at its highest in the Sep 2021 quarter at 1,288.17, when the stock price was $77.29 and the EPS was $0.06. The lowest value was in the Sep 2020 quarter, when it reached 16.15 with a price of $76.08 and an EPS of $4.71.
Biomarin Pharmaceutical PE ratio by year
Maximum annual decrease: -20.44% in 2023
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 108.34 | -20.44% |
| 2022 | 136.17 | N/A |
| 2021 | N/A | N/A |
| 2020 | 18.58 | N/A |
| 2019 | N/A | N/A |
| 2018 | N/A | N/A |
| 2017 | N/A | N/A |
| 2016 | N/A | N/A |
| 2015 | N/A | N/A |
| 2014 | N/A | N/A |
BMRN average PE ratio chart
BMRN's current P/E ratio is below the 3, 5 and 10-year averages.
BMRN PE vs peers
Compared to its peer stock CPRX, BMRN's PE ratio stands higher.
| Stock name | PE ratio | Market cap |
|---|---|---|
| CPRX Catalyst Pharmaceuticals Inc | 17.02 | $2.54B |
| BMRN Biomarin Pharmaceutical Inc | 38.62 | $12.51B |
| RARE Ultragenyx Pharmaceutical Inc | N/A | $4.08B |
| SGMO Sangamo Therapeutics Inc | N/A | $515.36M |
| FOLD Amicus Therapeutics Inc | N/A | $2.93B |
| ESPR Esperion Therapeutics Inc | N/A | $431.51M |
Frequently asked questions
What is Biomarin Pharmaceutical's PE ratio?
The price to earnings ratio for BMRN stock as of Dec 20, 2024, stands at 38.62.
What is the 3-year average PE ratio for Biomarin Pharmaceutical (BMRN)?
The 3-year average PE ratio for BMRN stock is 164.79.
What is the 5-year average PE ratio for Biomarin Pharmaceutical (BMRN)?
The 5-year average PE ratio for BMRN stock is 193.44.
What is the highest PE ratio for BMRN?
Over the last five years, the quarterly PE ratio reached a historic high of 1,288.17 in the Sep 2021 quarter.
How does the current PE ratio for BMRN compare to its historical average?
BMRN's price to earnings ratio is currently 80% below its 5-year historical average.
How is BMRN's PE ratio calculated (Biomarin Pharmaceutical PE ratio formula)?
To determine the PE ratio, divide the most recent stock price by the TTM earnings per share (EPS). As of today (Dec 20, 2024), Biomarin Pharmaceutical's stock price is $65.66. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $1.7. Therefore, Biomarin Pharmaceutical's P/E ratio for today is 38.62. PE RATIO(38.62) = STOCK PRICE($65.66) / TTM EPS($1.7)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.